Skip to main content
. 2017 Jul;63(7):512–520.

Table 4.

Additional agents active against MRSA not available in Canada

AGENT ROUTE STATUS (AT TIME OF WRITING)
Tedizolid Oral or IV Received NOC; not yet marketed
Ceftobiprole medocaril IV Received NOC; never marketed
Ceftaroline IV Not available
Dalbavancin IV (weekly) Not available
Oritavancin IV (1-time dose) Not available

IV—intravenous, MRSA—methicillin-resistant Staphylococcus aureus, NOC—Health Canada Notice of Compliance.